Defining the in vivo role of Huwe1 in p53 regulation
Defining the in vivo role of Huwe1 in p53 regulation
批准号:
9750257
负责人:
Manabu Kurokawa
金额:
$7.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-01 至 2020-11-03
关键词:
AcuteApoptosisCell Culture TechniquesCellsCellular StressComplexDNA DamageDataDevelopmentDisease modelDoseEmbryoEventFeedbackFibroblastsFutureGenetic TranscriptionGenotoxic StressGoalsHematopoietic stem cellsHomologous GeneHumanIntestinesKnock-outKnockout MiceLymphomagenesisMDM2 geneMalignant NeoplasmsMediatingMolecularMusMutationOncoproteinsOnset of illnessOrganOutcomePathway interactionsPlayPositioning AttributeProtein p53ProteinsPublishingRadiation therapyRegulationResistanceRoleSignal TransductionSkinSmall Interfering RNAStructure of beta Cell of isletTP53 geneTestingTherapeuticThymic LymphomaThymus GlandTissuesTransgenic MiceTumor Suppressor ProteinsUbiquitinationWorkcancer cellchemotherapyclinical predictorsdesignin vivoirradiationknock-downknockout genemouse modelneoplastic celloverexpressionpotential biomarkerpreventprotein degradationresponserestorationtooltumortumorigenesisubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
The tumor suppressor protein p53 is genetically inactivated in ~50% of human tumors. In tumor cells with wild
type p53, however, p53 activity is often suppressed in various other ways. In this regard, the ubiquitin E3 ligase
Mdm2 and its homolog, MdmX, are critical for the suppression of the activity of p53. Mdm2 and MdmX form
heterodimers which catalyze p53 protein degradation and block its transcriptional activity. Consequently,
elimination of both Mdm2 and MdmX is essential for full p53 activation. Despite numerous studies on the
regulation of p53 activity, the molecular mechanism that mediates the Mdm2-MdmX heterodimer degradation
remains poorly understood particularly in vivo. We have recently obtained results strongly indicating that the
HECT-domain ubiquitin E3 ligase Huwe1 may be the long-sought E3 ligase responsible for DNA damage-
induced degradation of both Mdm2 and MdmX. Importantly, Huwe1 was initially discovered as an E3 ligase that
ubiquitinates p53 for degradation. Nevertheless, our preliminary data show that: (a) Huwe1 interacts with both
Mdm2 and MdmX proteins independently of p53; (b) DNA damage-induced degradation of Mdm2 and MdmX
was markedly inhibited upon Huwe1 siRNA-mediated knockdown; and (c) Huwe1 knockdown renders cells
highly resistant to DNA damage-induced p53 activation by stabilizing both Mdm2 and MdmX. We hypothesize
that while suppressing steady-state p53 levels under non-stressed conditions, Huwe1 activates p53 by promoting
the degradation of Mdm2 and MdmX in response to genotoxic stress, an event critical for p53 activation. To test
this hypothesis in vivo, we created conditional Huwe1 knockout mouse models. Using the mouse models, we
will determine how acute deletion of Huwe1 impacts p53 activation before and after DNA damage (Aim 1) and
identify the impact of Huwe1 loss in DNA damage-induced thymic lymphomagenesis (Aim 2). The successful
completion of the proposed in vivo studies will provide the proof-of-concept evidence for the role of Huwe1 as a
crucial activator of p53 upon DNA damage. These outcomes will change the prevailing view of this controversial
E3 ligase and will also provide a rationale for revising the regulation of Mdm2/MdmX stability and impetus for
investigating the mechanism of Huwe1 regulation in the future.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3390/ijms24021345
发表时间:
2023-01-10
期刊:
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影响因子:
5.6
作者:
[Kaur, Sandeep, Kurokawa, Manabu]
通讯作者:
Kurokawa, Manabu
Role of the ubiquitin E3 ligase HUWE1 in age-associated nonalcoholic fatty liver disease
-
批准号:10648621
-
项目类别:
-
资助金额:$20.4万
-
财政年份:2023
-
负责人:Manabu Kurokawa
-
依托单位:
Molecular mechanisms of chemoresistance in breast cancer
-
批准号:8519642
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2012
-
负责人:Manabu Kurokawa
-
依托单位:
Molecular mechanisms of chemoresistance in breast cancer
-
批准号:8711023
-
项目类别:
-
资助金额:$22.92万
-
财政年份:2012
-
负责人:Manabu Kurokawa
-
依托单位:
Molecular mechanisms of chemoresistance in breast cancer
-
批准号:8536243
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2012
-
负责人:Manabu Kurokawa
-
依托单位:
Molecular mechanisms of chemoresistance in breast cancer
-
批准号:7892805
-
项目类别:
-
资助金额:$9.55万
-
财政年份:2010
-
负责人:Manabu Kurokawa
-
依托单位:
Molecular mechanisms of chemoresistance in breast cancer
-
批准号:8068839
-
项目类别:
-
资助金额:$9.74万
-
财政年份:2010
-
负责人:Manabu Kurokawa
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: